Table 3 The effect of non-coding RNA targeted therapy combined with IR in the treatment of ESCC
Non-coding RNA | Target | The effect | Reference |
|---|---|---|---|
miR-26b-5p | PTEN/PI3K/AKT signaling pathway | Radioresistance | [96] |
miR-205 | PTEN/PI3K/AKT signaling pathway | Radioresistance | [182] |
miR-519 | PI3K/AKT/mTOR signaling pathway | Radiosensitivity | [134] |
miR-4443 | PTPJR | Radioresistance | [183] |
miR-181a-2-3p | RAD17/Chk2 signaling pathway | Radiosensitivity | [176] |
miR-193a-3p | PSEN1 | Radioresistance | [184] |
miR-199a-5p | EEPD1/ATR/Chk1 signaling pathway | Radiosensitivity | [172] |
miR-301a | WNT1/β-catenin signaling pathway | Radiosensitivity | [45] |
miR-338-5p | survivin | Radiosensitivity | [167] |
miR-339-5p | CDC25A | Radiosensitivity | [185] |
miR-450a-5p | DUSP10 | Radiosensitivity | [186] |
LNCRNA FAM201A | miR-101-ATM/mTOR axis | Radioresistance | [187] |
LNCRNA MALAT1 | Cks1 | Radioresistance | [188] |
LNCRNA DNM3OS | PDGFβ/ PDGFβR/FOXO1 | Radioresistance | [73] |
LINC00473 | a) miR-497-5p/CDC25A axis b) miR-374a-5p/SPIN axis | Radioresistance | |
LINC01004 | LINC01004-SPI1 axis | Radioresistance | [86] |
circ-100,367 | miR-217/Wnt3 signaling pathway | Radioresistance | [191] |
circ-0014879 | miR-519-3p/CDC25A axis | Radioresistance | [192] |
circVRK1 | miR-624-3p/PTEN/PI3K/AKT signaling pathway | Radioresistance | [44] |